...
首页> 外文期刊>Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research >Persistent secondary hyperparathyroidism and vertebral fractures in kidney transplantation: role of calcium-sensing receptor polymorphisms and vitamin D deficiency.
【24h】

Persistent secondary hyperparathyroidism and vertebral fractures in kidney transplantation: role of calcium-sensing receptor polymorphisms and vitamin D deficiency.

机译:肾脏移植中持续的继发性甲状旁腺功能亢进和椎体骨折:钙敏感受体多态性和维生素D缺乏症的作用。

获取原文
获取原文并翻译 | 示例

摘要

Bone morbidity remains a major problem even after successful renal transplantation. We investigated the role of calcium-sensing receptor (CaSR) polymorphisms and 25-hydroxyvitamin D levels on the persistence of secondary hyperparathyroidism (SHPT) and their relationships with vertebral fractures (VFx) in 125 renal allograft recipients transplanted 44 +/- 23 months before. All patients underwent evaluation of the main biochemical parameters of calcium metabolism as well as vertebral and femoral bone density. In 87 patients, CaSR polymorphisms (A986S, R990G, and Q1011E) also were assessed. X-ray images of the lateral spine were obtained in 102 subjects to perform vertebral morphometry. High parathyroid hormone (PTH) and 25-hydroxyvitamin D lower than 80 nmol/L were found in 54% and 97% of patients, respectively, with 40% of these showing vitamin D levels lower than 30 nmol/L. VFx were detected in 57% of the subjects. After multiple adjustments, 25-hydroxyvitamin D, age, and hemodialysis duration, but not CaSR polymorphisms, were found to be significant predictors of high PTH, whereas age and time since transplant were positively related with lower 25-hydroxyvitamin D values. PTH and time since transplant were significantly associated with VFx. Patients with two or more VFx showed serum PTH levels 50% higher than patients without fractures. We therefore conclude that persistent SHPT is a very common feature after renal transplantation and that, unlike CaSR polymorphisms, low 25-hydroxyvitamin D is involved in its pathogenesis. High PTH levels, in turn, are associated with an increased VFx risk, which confirms the need for strategies aimed at lowering serum PTH in this setting as well.
机译:即使成功进行肾移植,骨发病率仍然是主要问题。我们调查了钙敏感受体(CaSR)多态性和25-羟基维生素D水平在继发性甲状旁腺功能亢进症(SHPT)持续性中的作用及其与125例44 +/- 23个月前移植的肾移植患者的椎体骨折(VFx)的关系。 。所有患者均接受了钙代谢以及椎骨和股骨密度的主要生化参数评估。在87例患者中,还评估了CaSR多态性(A986S,R990G和Q1011E)。在102位受试者中获得了外侧脊柱的X射线图像,以进行椎骨形态测量。分别在54%和97%的患者中发现甲状旁腺激素(PTH)和25-羟基维生素D低于80 nmol / L,其中40%的维生素D水平低于30 nmol / L。在57%的受试者中检测到VFx。经过多次调整后,发现25-羟基维生素D,年龄和血液透析持续时间(而非CaSR多态性)是高PTH的重要预测指标,而移植后的年龄和时间与25-羟基维生素D值较低呈正相关。自移植以来的PTH和时间与VFx显着相关。有两个或更多VFx的患者的血清PTH水平比没有骨折的患者高50%。因此,我们得出结论,持续性SHPT是肾移植后的一个非常普遍的特征,并且与CaSR多态性不同,低25-羟基维生素D参与了其发病机理。反过来,高PTH水平会增加VFx风险,这也证实了在这种情况下也需要旨在降低血清PTH的策略。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号